Get my own profile
Public access
View all39 articles
3 articles
available
not available
Based on funding mandates
Co-authors
Xiao QinMRC Translational Immune Discovery Unit, MRC WIMM, University of OxfordVerified email at rdm.ox.ac.uk
Ferran Cardoso RodriguezSenior Scientific Officer, the Institute of Cancer Research, UKVerified email at icr.ac.uk
Dr Sophie E. Acton (Pinner)Laboratory for Molecular Cell Biology, University College LondonVerified email at ucl.ac.uk
Jonathan WorboysThe University of ManchesterVerified email at manchester.ac.uk
Douglas LauffenburgerMITVerified email at mit.edu
Stephanie LingAssociate Director, AstraZenecaVerified email at astrazeneca.com
Vivian S.W. LiThe Francis Crick InstituteVerified email at crick.ac.uk
George PoulogiannisThe Institute of Cancer Research, LondonVerified email at icr.ac.uk
Rebecca LeeThe University of ManchesterVerified email at manchester.ac.uk
Amine SadokSr. Director-Head of Discovery Technologies at Monte Rosa TherapeuticsVerified email at monterosatx.com
Smita KrishnaswamyYale UniversityVerified email at yale.edu
Jeroen ClausCancer Research UK London Research InstituteVerified email at phospho.co.uk
Oscar MaiquesBarts Cancer Institute -Queen Mary University of LondonVerified email at qmul.ac.uk
Victoria Sanz MorenoProfessor of Cancer Cell and Metastasis Biology, The Institute of Cancer ResearchVerified email at icr.ac.uk
Chris BakalTeam Leader, Chester Beatty Laboratories, Institute of Cancer ResearchVerified email at icr.ac.uk
Faraz MardakhehDepartment of Biochemistry, University of OxfordVerified email at bioch.ox.ac.uk
Heba Z SailemKing's College LondonVerified email at kcl.ac.uk
Alexander TongMila; Université de MontréalVerified email at mila.quebec
James OpzoomerRelation TherapeuticsVerified email at relationrx.com
Erik SahaiFrancis Crick InstituteVerified email at crick.ac.uk
Follow
Christopher Tape
Group Leader, University College London Cancer Institute
Verified email at ucl.ac.uk - Homepage